SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 233 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $649,599 | -8.3% | 23,566 | +0.0% | 0.00% | – |
| Q2 2023 | $708,421 | -17.1% | 23,563 | -0.1% | 0.00% | -100.0% |
| Q1 2023 | $854,048 | +123.9% | 23,589 | +120.6% | 0.00% | – |
| Q4 2022 | $381,387 | +5.3% | 10,695 | -50.0% | 0.00% | – |
| Q3 2022 | $362,362 | +17.3% | 21,390 | +100.2% | 0.00% | – |
| Q2 2022 | $309,000 | -85.1% | 10,683 | -83.4% | 0.00% | -100.0% |
| Q1 2022 | $2,076,000 | -12.8% | 64,226 | -21.3% | 0.00% | 0.0% |
| Q4 2021 | $2,380,000 | +20.4% | 81,621 | +10.1% | 0.00% | 0.0% |
| Q3 2021 | $1,977,000 | -26.3% | 74,127 | -14.9% | 0.00% | 0.0% |
| Q2 2021 | $2,682,000 | +3.5% | 87,110 | -12.0% | 0.00% | 0.0% |
| Q1 2021 | $2,591,000 | +38.6% | 98,963 | +33.1% | 0.00% | 0.0% |
| Q4 2020 | $1,870,000 | +33.7% | 74,343 | +10.7% | 0.00% | 0.0% |
| Q3 2020 | $1,399,000 | -4.4% | 67,127 | +8.9% | 0.00% | 0.0% |
| Q2 2020 | $1,463,000 | +153.1% | 61,615 | +91.7% | 0.00% | – |
| Q1 2020 | $578,000 | -19.9% | 32,142 | +5.6% | 0.00% | – |
| Q4 2019 | $722,000 | -96.1% | 30,447 | -95.4% | 0.00% | -100.0% |
| Q3 2019 | $18,291,000 | -16.3% | 665,627 | +0.8% | 0.01% | -16.7% |
| Q2 2019 | $21,857,000 | -7.0% | 660,520 | -1.5% | 0.01% | -7.7% |
| Q1 2019 | $23,505,000 | +10.4% | 670,795 | +4.7% | 0.01% | -7.1% |
| Q4 2018 | $21,289,000 | -35.9% | 640,846 | -2.8% | 0.01% | -22.2% |
| Q3 2018 | $33,197,000 | -16.6% | 659,330 | -0.9% | 0.02% | -21.7% |
| Q2 2018 | $39,824,000 | +58.9% | 665,392 | +21.6% | 0.02% | +53.3% |
| Q1 2018 | $25,057,000 | +48.3% | 547,103 | +29.0% | 0.02% | +50.0% |
| Q4 2017 | $16,897,000 | +58.7% | 424,021 | +59.3% | 0.01% | +42.9% |
| Q3 2017 | $10,646,000 | – | 266,146 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |